
Precision BioSciences Announces New and Late-Breaking PBGENE-HBV Clinical Data from the ELIMINATE-B Study at European Association for the Study of the Liver Congress 2026
<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxNU0ZmSlBwM19JMEdyV0NvZ2hNM0dPdEd0Q3p1NkN3R3Bibms1NFhWT1pPQm1GQ2dmZGpnSWhJa1VRNmZ3OUlCMnU2ZDdYdGlpZTBVak5nOG1oT1dPbXRnMVN0NjFZTW8wNnZTUk55ZkZQdmc2T2hucVZJMXJmLU9FclVzcDNBQ3Z0LWxSclFzWUNNV1NTWUNxYjFSNVFzQ25tMk5jbnF6N3VBTUJYOXhSQ2lPRmZabGVlQWlwYTlQUG52Nll6a0x2VmlIbFA1WmVNWW1PWloxZlpHZw?oc=5" target="_blank">Precision BioSciences Announces New and Late-Breaking PBGENE-HBV Clinical Data from the ELIMINATE-B Study at European Association for the Study of the Liver Congress 2026</a>&nbsp;&nbsp;<font color="#6f6f6f">Precision BioSciences</font>

